IRIDIAN ASSET MANAGEMENT LLC/CT

Holdings History for RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA)

Symbol: DNA on NYSE
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0%	$0	0	-23,234	-100%		Q3 2024
30 Jun 2024	0%	0%	$7,767	23,234	0		$0.33	Q2 2024
31 Mar 2024	0.01%	+0%	$26,951	23,234	+5,189	+29%	$1.16	Q1 2024
31 Dec 2023	0.01%	0%	$30,496	18,045	0		$1.69	Q4 2023
30 Sep 2023	0.01%	-0%	$32,661	18,045	-3,860	-18%	$1.81	Q3 2023
30 Jun 2023	0%	-0%	$40,743	21,905	-2,153	-8.9%	$1.86	Q2 2023
31 Mar 2023	0%	+0%	$31,997	24,058	+13,163	+121%	$1.33	Q1 2023
31 Dec 2022	0%	+0%	$18,000	10,895	+10,895	NEW	$1.65	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.